Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord. The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer interface to the ARCIM to restore thought-driven movement of the upper and lower limbs. Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Metrics to compare | ONWD | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipONWDPeersSector | |
---|---|---|---|---|
P/E Ratio | −4.6x | −2.7x | −0.7x | |
PEG Ratio | −0.64 | −0.10 | 0.00 | |
Price/Book | 8.9x | 2.2x | 2.6x | |
Price / LTM Sales | −867.6x | 2.6x | 3.2x | |
Upside (Analyst Target) | 197.2% | 23.4% | 46.6% | |
Fair Value Upside | Unlock | 10.2% | 7.4% | Unlock |